Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
Clinical efficacy and safety of zoledronic acid in osteoporosis and Pagets bone disease
Expert Review of Endocrinology & Metabolism, 09/23/09
Doggrell SA – Osteoporosis and Paget’s bone disease are the most common diseases of the bone. In addition to glucocorticoid treatment, there are many other secondary causes of osteoporosis. This article also covers the studies of the effects of zoledronic acid in the bone loss associated with the secondary osteoporosis.
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Pattern of Bone Mineral Density in Sickle Cell Disease Patients with the High-Hb F Phenotype
Acta Haematologica, 12/04/09
Monitoring osteoporosis treatment
Best Practice & Research: Clinical Rheumatology, 12/04/09
Three-dimensional osseous micro-architecture of the distal humerus: Implications for internal fixation of osteoporotic fracture
Journal of Shoulder and Elbow Surgery, 12/04/09
Article Search
Sponsor


See Latest Articles


